Wasatch Clinical Research

Salt Lake City, Utah 84157

2 studies enrolling now · 56 studies all time

What they study most

AD, Alzheimer Disease, Alzheimer Disease 1, Alzheimer Disease 10, Alzheimer Disease 11, Alzheimer Disease 12, Alzheimer Disease 13, Alzheimer Disease 14, Alzheimer Disease 15, Alzheimer Disease 16, Alzheimer Disease 17, Alzheimer Disease 18

Studies at this site

• A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer — Recruiting now
• A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain — Completed
• Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential — Running, not enrolling
• A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) — Running, not enrolling
• Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee — Completed
• Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee — Completed
• 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee — Running, not enrolling
• Safety and Efficacy Study of MT-2990 in Women With Endometriosis — Completed
• Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive — Stopped early
• Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults — Completed
• Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS — Running, not enrolling
• A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain — Completed
• Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) — Completed
• Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine — Running, not enrolling
• A Study of Seltorexant in Participants With Probable Alzheimer's Disease — Completed
• Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) — Enrolling by invitation
• A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab — Completed
• DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis — Completed
• Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain — Completed
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
• SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study — Completed
• A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease — Status unconfirmed
• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis — Completed
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
• A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy — Stopped early
• MLE4901 vs. Placebo for the Treatment of PCOS — Stopped early
• Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
• Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes — Completed
• Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01) — Stopped early
• A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval — Completed
• Study of DA-9801 to Treat Diabetic Neuropathy — Completed
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) — Completed
• Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes — Completed
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine — Completed
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ — Stopped early
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed
• Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed